Could China’s journey of malaria elimination extend to Africa? - Infectious Diseases of Poverty

COVID-19 Vaccines in Patients with Decompensated Cirrhosis: A Retrospective Collection on Safety Data and Risk Factors Associated with Unvaccinated Status – Poverty Infectious Diseases

  • Shahidsales S, Aledavood SA, Joudi M, Molaie F, Esmaily H, Javadinia SA. Symptoms of COVID-19 in cancer patients may present with atypical symptoms and higher mortality, a controlled study from Iran. Cancer representative (Hoboken). 2021; 4 (5): e1378.

    Google Scholar CAS

  • Tagizadeh Hosari F, Boruhan F, Soroush D, Piroshbani B, Javadina SA. COVID-19 in cancer and non-cancer patients. Int J Cancer Manag. 2021; 14: e110907.

    Google Scholar article

  • Javadinia SA, Ariamanesh M, Nabavifard M, Porouhan P, PeyroShabany B, Fazilat-Panah D et al. A multicenter study of the seroprevalence of antibodies against COVID-19 in patients presenting to Iranian cancer centers one year after the COVID-19 pandemic. Cancer investment. 2022; 40 (2): 115-23.

    Article CAS Scholar from Google

  • Su F. COVID-19 and cirrhosis: a combination we should strive to prevent. Gastrointestinal diseases. 2021; 161 (5): 1371–3.

    Article CAS Scholar from Google

  • Margot T, Moon AM, Cook GA, Abdus Salam S, Allman C, Armstrong MG, et al. The following outcomes of SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021; 74 (3): 567–77.

    Article CAS Scholar from Google

  • Iavarone M, D’Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P et al. High 30-day mortality rates in patients with cirrhosis and COVID-19. J Hepatol. 2020; 73 (5): 1063–71.

    Article CAS Scholar from Google

  • Ioannou GN, Liang PS, Locke E, Green P, Berry K, O’Hare AM et al. Cirrhosis and severe acute respiratory syndrome coronavirus 2 infection in US veterans: risk of infection, hospitalization, ventilation, and death. Liver diseases. 2021; 74 (1): 322–35.

    Article CAS Scholar from Google

  • Ge J, Pletcher MJ, Lai JC, Harper JR, Chute CG, Haendel MA. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national cohort COVID-19 collaborative study. Gastrointestinal diseases. 2021; 161 (5): 1487-501.e5.

    Article CAS Scholar from Google

  • Moon AM, Webb GJ, Aloman C, Armstrong MJ, Cargill T, Dhanasekaran R et al. High mortality rates from SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: preliminary results from the international registry. J Hepatol. 2020; 73 (3): 705-8.

    Article CAS Scholar from Google

  • Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, et al. Consensus statement of the American Association for the Study of Liver Diseases expert committee: Vaccines to prevent 2019-nCoV in patients with hepatitis. Liver diseases. 2021; 74 (2): 1049-1064.

    Article CAS Scholar from Google

  • Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL, Position paper on the use of COVID-19 vaccines in patients with chronic liver disease, hepatocellular carcinoma and liver transplant recipients. J Hepatol. 2021; 74 (4): 944-51.

    Article CAS Scholar from Google

  • Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, et al. SARS-CoV2-specific humoral response and T-cell immune response after second vaccination in cirrhosis and liver transplant patients. Clin Gastroenterol Hepatol. 2022; 20 (1): 162–72.e9.

    Article CAS Scholar from Google

  • John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among cirrhosis patients. Gamma Intern Med. 2021; 181 (10): 1306-14.

    Article CAS Scholar from Google

  • John BV, Deng Y, Schwartz KB, Taddei TH, Kaplan DE, Martin P et al. Post-vaccination COVID-19 infection is associated with lower mortality in patients with cirrhosis. Liver diseases. 2022. https://doi.org/10.1002/hep.32337.

    Google Scholar PubMed Article

  • Mahmoud N, Shabin Siraj, Kaplan D, Serber M. Liver transplant. 2021; 27 (11): 1665-168.

    Google Scholar article

  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K et al. Global survey of potential acceptance of a COVID-19 vaccine. nat med. 2021; 27 (2): 225-8.

    Article CAS Scholar from Google

  • Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. Vaccination readiness against COVID-19 among Chinese adults under the free vaccination policy. Vaccines (Basel). 2021; 9 (3): 292.

    Article CAS Scholar from Google

  • Marjot T, Webb GJ, Barritt AS, Ginès P, Lohse AW, Moon AM et al. SARS-CoV-2 vaccination in hepatitis patients: answering the next big question. Lancet Gastroenterol Hepatol. 2021; 6 (3): 156-8.

    Google Scholar article

  • Cao Z, Liu Y, Cai M, Xu Y, Xiang X, Zhao G et al. Use of the ACLF’s NACSELD and EASL-CLIF classification systems in predicting prognosis in hospitalized cirrhotic patients. I j Gastroenterol. 2020; 115 (12): 2026–35.

    Google Scholar article

  • Cui X, Wang P, Wei Z. Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021. Drug Discov Ther. 2021; 15 (4): 222-4.

    Article CAS Scholar from Google

  • 90% of Chinese have been vaccinated against COVID-19. Available at http://en.nhc.gov.cn/2022-01/17/c_85646.html. Accessed February 5, 2022; Posted online.

  • Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB. Liver injury after SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022; 76 (1): 211–4.

    Article CAS Scholar from Google

  • Autoimmune hepatitis Pril F after coronavirus 2019 (COVID-19) vaccine: One swallow or even several swallows don’t make summer. J Hepatol. 2021; 75 (5): 1256–7.

    Article CAS Scholar from Google

  • Cao Z, Gui H, Sheng Z, Xin H, Xie Q. Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination. Liver diseases. 2022; 75 (3): 757-9.

    Article CAS Scholar from Google

  • Ai J, Wang J, Liu D, Xiang H, Guo Y, Lv J et al. Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver disease (CHESS-NMCID 2101): a multicenter study. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.12.022.

    PubMed Article PubMed Central Google Scholar

  • Wang J, Hou Z, Liu J, et al. Safety and immunogenicity of the COVID-19 vaccine in patients with nonalcoholic fatty liver disease (CHESS2101): a multicenter study. J Hepatol. 2021; 75 (2): 439-41.

    Article CAS Scholar from Google

  • She T, Zhou Y, Xu P, Ling N, Chen M, Huang T et al. Safety and antibody response to an inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection. Liver Int. 2022. https://doi.org/10.1111/liv.15173.

    Google Scholar PubMed Article

  • Singh S, Khan A. Clinical characteristics and outcome of 2019-nCoV among patients with pre-existing liver disease in the United States: a multicenter research network study. Gastrointestinal diseases. 2020; 159 (2): 768-71.e3.

    Article CAS Scholar from Google

  • Bajaj JS, Garcia-Tsao G, Biggins SW, Kamath PS, Wong F, McGeorge S et al. Comparison of mortality risks in patients with cirrhosis and COVID-19 compared with patients with cirrhosis and COVID-19 alone: ​​a multicenter matching group. Gut. 2021; 70 (3): 531-6.

    Article CAS Scholar from Google

  • Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S et al. Pre-existing liver disease is associated with poor outcome in patients with SARS-CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020; 14 (5): 690-700.

    Google Scholar article

  • Wu J, Li Qiu, Silver Tarimu C, Wang M, Ju J, Wei W, et al. COVID-19 vaccine frequency among the Chinese population: a large-scale national study. immune front. 2021; 12: 781161.

    Google Scholar article

  • Velardo F, Watson V, Arwidson P, Alla F, Luchini S, Schwarzinger M et al. Regional differences in COVID-19 vaccine frequency in December 2020: a natural experiment in a French working-age population. Vaccines. 2021; 9 (11): 1364.

    Article CAS Scholar from Google

  • Valckx S, Crèvecoeur J, Verelst F, Vranckx M, Hendrickx G, Hens N et al. Individual factors influencing COVID-19 vaccine acceptance between and during pandemic waves (July-December 2020). Serum. 2022; 40 (1): 151-61.

    Article CAS Scholar from Google

  • Joudi M, Moradi Binabaj M, Porouhan P, PeyroShabany B, Tabasi M, Fazilat-Panah D et al. Cohort study on the immunogenicity and safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in breast cancer patients; Does trastuzumab interfere with the result? Front Endocrinol. 2022; 13: 798975. https://doi.org/10.3389/fendo.2022.798975.

    Google Scholar article

  • 2022-05-16 08:08:57

    Leave a Comment

    Your email address will not be published.